It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2002.
2002 | Mumbai, Maharashtra, India | Under LiquidationAril Pharma Limited, a under liquidation public limited company, was established on 06 November 2002 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33110MH2002PLC137788. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.55 M.
Its leadership includes Vijay Kumar Chopra (Additional Director), Satish Surana (Additional Director), Vaibhav Purnandu Jain (Director). Past directors included Satish Surana, Yashwant Surana, Vaibhav Purnandu Jain. It holds no open charges and ₹19.00 Cr settled loans. Its latest AGM occurred on 30 September 2011, with the balance sheet filed on 31 March 2011. It is based at C-302, Crystal Plaza, Andheri Link Road, Andheri (West), Mumbai, Maharashtra, 400053.
U33110MH2002PLC137788
137788
06 November 2002
₹2.50 M
₹1.55 M
Roc Mumbai
Unlisted
Under Liquidation
Explore comprehensive insights into Aril Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Kumar Chopra | Additional Director | 12 Jan 2009 | Current |
| Satish Surana | Additional Director | 24 Aug 2009 | Current |
| Vaibhav Purnandu Jain | Director | 04 Apr 2008 | Current |
| Anupama Purnandu Jain | Director | 30 Sep 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Jul 2014 | Past |
| Pramod Abcsdd | Director | 01 Oct 2011 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2008 | Past |
| Pramod Abcsdd | Director | 04 Apr 2008 | Past |
| Pramod Abcsdd | Director | 24 Mar 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Aril Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Aril Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹190,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2004 | State Bank Of India | ₹9.00 Cr | Satisfied |
| 23 Jan 2004 | State Bank Of India | ₹6.00 Cr | Satisfied |
| 23 Jan 2004 | State Bank Of India | ₹4.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Aril Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aril Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aril Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aril Pharma Limited last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records. was documented.
The activity Aril Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Mumbai. was completed.
Progress on Satish Surana was appointed as a Additional Director was appointed as a Additional Director on 24 Aug 2009 & has been associated with this company since 16 years 3 months . was documented.
The activity Vijay Kumar Chopra was appointed as a Additional Director was appointed as a Additional Director on 12 Jan 2009 & has been associated with this company since 16 years 10 months . was completed.
Progress on Vaibhav Purnandu Jain was appointed as a Director was appointed as a Director on 04 Apr 2008 & has been associated with this company since 17 years 7 months . was documented.
Progress on A charge registered on 28 Dec 2004 via Charge ID 80027280 with State Bank Of India was fully satisfied on 12 Apr 2007. was documented.
The CIN of Aril Pharma Limited is U33110MH2002PLC137788.
Aril Pharma Limited is headquartered at C-302, Crystal Plaza, Andheri Link Road, Andheri (West), Mumbai, Maharashtra, 400053.
Aril Pharma Limited was incorporated on 06 November 2002.
The current directors of Aril Pharma Limited are
The primary industry of Aril Pharma Limited is Pharma.
Aril Pharma Limited is unlisted.
The authorized capital of Aril Pharma Limited is ₹2.50 M, and the paid-up capital is ₹1.55 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX